Sander Slootweg

Equibles does not estimate personal net worth.

About Sander Slootweg

Sander Slootweg was last confirmed as Board Member at Replimune Group, Inc. (REPL) in a filing dated July 27, 2022. NewAmsterdam Pharma Co N.V. reported in an 8-K filed July 18, 2024 that Sander Slootweg resigned as member of the Company's board of directors, effective July 16, 2024.

“On July 16, 2024, Sander Slootweg notified NewAmsterdam Pharma Company N.V. (the "Company") of his decision to resign as a member of the Company's board of directors (the "Board") effective immediately.”

NewAmsterdam Pharma Co N.V. Form 8-K, filed July 18, 2024 · Read the filing

Affiliation history

Replimune Group, Inc. (REPL)
Board Member

Proxy statement

Start not stated–2022-07-27

Last confirmed by a filing; no departure on record

Company network

Replimune Group, Inc.

REPL

Biotechnology · Healthcare

Board Member

Recent activity

Executive change Resigned: member of the Company's board of directors NewAmsterdam Pharma Co N.V. (NAMS)
2024-07-16